Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires. The generics and biosimilars arm of ...

A video has gone viral on X allegedly showing Marine Le Pen greeting scores of fans in Paris following a court ruling that banned her from running for public office for five years. In the video ...

After years of patent protection, biosimilars for Humira are set to enter the US market in 2023. The arrival of these drugs has been widely anticipated throughout the healthcare industry.

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. The candidate fell short in a phase 2 psoriasis trial, prompting the French drugmaker to pull back from plans to ...

Lionel Messi has made the nearly seven-hour flight to Vancouver after missing the trip in 2024. / Sam Navarro-Imagn Images After defeating Columbus Crew SC 1–0 on Matchday 9 to become the last ...

CF Industries Holdings, Inc., together with its subsidiaries, engages in the manufacture and sale of hydrogen and nitrogen products for energy, fertilizer, emissions abatement, and other ...

SUNDAY, HE’LL HOS A mission that started with a pen pal program offering Maryland students a chance to connect with young people in Kenya has the same goal as 23 years ago.If students can ready ...

Humira's loss of exclusivity has created headwinds as biosimilar competition erodes market share. However, AbbVie's newer immunology treatments, Skyrizi and Rinvoq, have demonstrated stronger ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.